Three patients with chronic renal failure received fentanyl 0.5 mg and suxamethonium 40 mg intravenously. Vasoactivity attributed to suxamethonium and loss of consciousness were noted. Cardiorespiratory effects of unsupplemented fentanyl 0.5 mg injected slowly were not significant in four chronically azotaemic patients. After morphine 100 mg was administered intravenously over a period of 10 minutes a characteristic fall in arterial oxygen tension was observed to a more pronounced degree than after fentanyl. Carbon dioxide responses were similar. There were no delayed sequelae in the fentanyl recipients. After morphine 100 mg there was a latent period of freedom from clinical side effects for 6 hours in the first and 95 minutes in the second patient, at which times deep coma persisting for 72 hours supervened in both.
Three patients with chronic renal failure received fentanyl 0.5 mg and suxamethonium 40 mg intravenously. Vasoactivity attributed to suxamethonium and loss of consciousness were noted. Cardiorespiratory effects of unsupplemented fentanyl 0.5 mg injected slowly were not significant in four chronically azotaemic patients. After morphine 100 mg was administered intravenously over a period of 10 minutes a characteristic fall in arterial oxygen tension was observed to a more pronounced degree than after fentanyl. Carbon dioxide responses were similar. There were no delayed sequelae in the fentanyl recipients. After morphine 100 mg there was a latent period of freedom from clinical side effects for 6 hours in the first and 95 minutes in the second patient, at which times deep coma persisting for 72 hours supervened in both.
Lowenstein and his colleagues (1969) have used single intravenous doses of morphine 1 mg/kg and Grell, Koons and Denson (1970) reported on the use of fentanyl 0.5 mg to provide anaesthesia for major surgery. Fentanyl is generally preferred because it is ultra-short-acting in comparison with morphine (Guertner, Doenicke and Spiess, 1964) . Finch and DeKornfeld (1967) found that the duration of action of equipotent doses of the two drugs was similar in two postoperative studies in which fentanyl 0.05 mg and 0.2 mg respectively were compared in each instance with morphine 10 mg.
We designed an experimental study to compare the duration of measurable effects of fentanyl 0.5 mg and morphine 100 mg in patients with endstage renal disease being treated by haemodialysis. These metabolically deficient patients were chosen because the sparing effects which Lowenstein and associates (1969) noted to be associated with morphine anaesthesia suggested to us that it might be the most suitable anaesthetic for the increasing number of surgical procedures which are being performed in these patients. 
METHOD
Nine patients undergoing regular haemodialysis treatment for chronic renal failure were studied in the manner previously described (Mostert et al. 3 1970a, b) . In brief, right heart intracardiac measurements, systemic pressures and cardiac outputs were determined. Indocyanine green was injected into the right ventricle and blood was withdrawn from a brachial artery through a photo-electric densitometer. A Lexington cardiac output computer and a Volemetron were used to facilitate measurement of cardiac output and blood volume.
Fentanyl 0.5 mg was given rapidly intravenously to three patients in association with suxamethonium and artificial ventilation. Four additional patients were given fentanyl 0.5 mg intravenously over a period of 10 minutes to allow retention of consciousness. Two patients were given morphine 100 mg intravenously over a period of 10 minutes. Measurements made before administration of the drugs were repeated 5, 10, 30 and 60 minutes after completion of the injections. The patients were kept under observation, and in those who had been given suxamethonium manual ventilation with 100 per cent oxygen was maintained until spontaneous respiration reappeared. The conscious patients were instructed to take deep breaths from the first appearance of respiratory depression.
RESULTS
Effects of fentanyl 0.5 mg in association with suxamethonium 40 mg. Table I shows that none of the cardiac output changes achieved significance. There were no significant changes in arterial pressure. Total peripheral resistance was significantly decreased at the 5-minute measurements only. There was significant bradycardia 30 and 60 minutes after the drugs, and significant depression of right ventricular systolic pressure 60 minutes after the drugs. The mean haematocrit was 20 per cent. The majority of patients were hypervolaemic (mean predicted blood volume 4300 ml, and mean measured blood volume 520O ml). In all three patients there was complete amnesia for the apnoeic period.
Effects of fentanyl 0.5 mg by slow intravenous injection. Table II gives the effects of unsupplemented fentanyl 0.5 mg given slowly intravenously to four patients. There were significant haemodynamic changes at 10 and 30 minutes only, when the total resistance was decreased. At 30 minutes there was a significant elevation of arterial oxygen tension. These changes were accompanied by an initial (but non-significant) depression of arterial oxygen tension ( fig. 1 Tables III and IV give the individual results of the two recipients of morphine 100 mg. There was striking elevation of cardiac output accompanied by corresponding fall of total peripheral resistance. In spite of this, arterial blood-gas values deteriorated promptly and progressively after administration of morphine ( fig. 1 and tables III and IV). The Central effects of morphine 100 mg. The first morphine recipient remained awake and co-operative throughout the hour of study and she did not have to be reminded to breathe consciously. She remained under observation for another hour, and then received ketamine 2 mg/kg and tubocurarine 18 mg in association with nitrous oxide and oxygen for performance of open renal biopsy. At the end of the operation she was given neostigmine 4 mg and atropine 1.2 mg. Consciousness with full orientation was regained after a delay of 90 minutes. Shortly afterwards she underwent renal scanning, and was sent to her ward 6 hours after receiving morphine. At this time it was noted that the patient was not responsive to vocal stimuli. A thorough physical and biochemical examination failed to establish the cause of deep coma which persisted for 3 days. After two dialysis treatments each lasting 6 hours she became responsive to painful stimuli. After the third 6-hour period of dialysis on the third postoperative day she regained consciousness in the afternoon. She did not receive artificial respiration and there were no other sequelae. She has remained well on 6 hours of haemodialysis twice a week.
The second morphine recipient (male, aged 62 years) remained alert and did not have to be instructed to take deep breaths for 95 minutes after the drug was injected. At that time, however, cyanosis appeared, endotracheal intubation was easily carried out and artificial ventilation had to be used. Levallorphan tartrate 5 mg intra- venously restored complete consciousness and extubation was carried out. Ten minutes later coma recurred and intubation with artificial respiration again became mandatory. More levallorphan and other stimulants were ineffective and artificial respiration had to be used for 72 hours. A tracheostomy was performed after 24 hours. Haemodialysis was performed for 6 hours every day, and on the third day, in the late afternoon, the patient gradually began to recognize his relaatives. The further history of this patient included no other sequelae.
Both recipients of morphine had normal liver function tests. The 62-year-old male gave a history of chronic bronchitis, and tracheostomy became necessary in him for removal of abnormal secretions. Fine twitching of the facial muscles was a feature of the coma in both instances. Consultant neurologists failed to uncover localizing signs. In view of normal blood osmolality and chemistry the clinical diagnosis of toxic encephalopathy was made.
DISCUSSION
Fentanyl 0.5 mg administered rapidly intravenously in association with suxamethonium, seemed to be effective as an anaesthetic. The haemodynamic changes observed seemed to be those consistent with injection of suxamethonium alone (see Conway, 1961, and Adams and Hall, 1962) , because when unsupplemented fentanyl 0.5 mg was slowly injected only the early and transitory depression of Pao, which we invariably observe after the intravenous injection of any narcotic (Mostert et al., 1970b) supervened. The subjects of the present study who had chronic end-stage renal failure and were being maintained on twice-weekly haemodialysis, are probably more homogeneous as regards the side effects of drugs than any other patient-population (Reidenberg, 1971) . Our results in the two patients who received morphine 100 mg are therefore comparable to the observed effects of fentanyl especially since the drugs were given in a random fashion. It was only after both mishaps that morphine was identified as the offending agent. In the second recipient of morphine the complete but transient recovery which followed injection of the narcotic antagonist confirmed that morphine was indeed the cause of the coma.
The present study shows striking circulatory stimulation after morphine 100 mg and almost complete absence of circulatory changes after fentanyl 0.5 mg. The deterioration in blood-gas values was prompt and inexorable after morphine and of little or no significance after fentanyl when it simply showed the "trade-mark" of any narcotic resulting in fleeting depression of Pao,. This is consistent with the work of Lowenstein and associates (1969) and Kehm, Mack and Schlobohm (1970) who described the value of morphine anaesthesia for cardiac surgery, and the work of Grell, Koons and Denson (1970) , who described the safe use of large doses of intravenous fentanyl to potentiate nitrous oxide anaesthesia. However, our study shows that morphine anaesthesia is absolutely unsuitable for patients with chronic renal failure and relatively unsuitable for patients undergoing open-heart surgery and who may develop acute renal failure before the drug is excreted.
The most important finding of the present study is the demonstration that cardiorespiratory effects of morphine and fentanyl can be noted a few minutes after injection of the drugs, but that peak central effects of morphine may not occur for many hours after it is injected intravenously. DeStevens (1965) noted that peak effects of morphine may not occur for an hour or more although this has not been described in connection with morphine anaesthesia.
The devastating central effects of morphine reported in this paper can be explained as follows. Sollman (1957) stated that the principal disadvantage of morphine is its inherent and characteristic inhibition of psychomotor activity. Thus morphine provides better tranquillization and immobility with greater respiratory depression than fentanyl. Fink (1961) postulated that the magnitude of respiratory activity was one yardstick of the level of consciousness, so that as consciousness is lost there is a corresponding and directly related degree of respiratory depression as seen, for example, in normal sleep. Central (anaesthetic) effects of fentanyl were evident in our cases when suxamethonium was used simultaneously, but were evanescent and did not recur. This suggests that fentanyl and morphine are excreted by different mechanisms. Like all other drugs, morphine and fentanyl are eliminated from the body at a rate proportional to the plasma concentration after equilibrium has been reached with the tissues. The length of time needed for plasma concentration to fall to one-half its initial value (drug half-life) is given by the formula:
Volume of distribution Drug clearance Brodie (1968) calculated drug half-lives by using volumes of distribution representing total body water (50 1.), extracellular water (15 1.), and extensive intracellular binding (70,000 1.)-Renal excretion represents glomerular filtration with tubular reabsorption (1 ml/min), glomerular nitration alone (125 ml/min) and glomerular nitration plus tubular secretion (700 ml/min). Thus, the effect of decreasing renal function on the half-life of morphine can be calculated as shown in table V. All the patients in the present study had creatinine clearances of less than 5 ml/min. The disastrous results of morphine anaesthesia are probably not the result of a special type of cerebral toxicity but simply due to the dramatic prolongation of the half-life of the drug in chronic renal failure and gradual accumulation of morphine and its metabolites in the central nervous system. Morphine is concentrated by the choroid plexus by an active transport mechanism. Central nervous system effects and toxicity appear to be related to the concentration of free morphine (or closely related derivatives) in the cerebral grey matter. Most of the injected morphine is glucuronated in the liver, 3-0 methylated to codeine or N-demethylated to normorphine; 60-90 per cent of the free and conjugated derivatives are excreted in the urine, about 10 per cent are excreted into the faeces (chiefly through the bile and gastric juice), saliva and sweat. It is possible that in the absence of renal excretion, morphine and its derivatives gradually reached toxic central nervous system levels in the face of continued active transport and the reservoir function of complex forms and continuously forming metabolites. Some of these metabolites are more toxic than morphine (e.g. normorphine). These considerations also suggest that the biotransformation of fentanyl is not dependent on renal excretion of the active drug.
An interesting corollary of the circulatory stimulation after large doses of morphine is the decrease in blood lactate concentrations below normal levels which DiFazio and Chen (1971) have described after large intravenous doses of morphine in man. We have found the resting arterial lactate concentration to be significantly elevated in patients with chronic renal failure. Morphine is therefore valuable in supporting and even benefiting aerobic cellular metabolism and circulatory haemodynamics provided the depressant effects on pulmonary ventilation are remedied by artificial ventilation.
Tolerance to morphine does not develop in rodents if protein-synthesis inhibitors are given (Oswald, 1969) and protein synthesis may be impaired in chronic renal failure. However, antibodies to morphine made antigenic by covalent binding to protein have been produced experimentally by Spector of the Roche Institute of Molecular Biology, Nutley, New Jersey (personal communication, 1971 ) so that allergic hypersensitivity to morphine is possible as mentioned by Schreiner and Maher (1961) . However, both the morphine recipients described in the present paper reacted normally to morphine 10 mg given to each before arteriovenous-shunt surgery subsequent to the persistent comas. Ke6ri-Szanto (1961) noted that suxamethonium may sometimes have an anaesthetic effect in man, and our experimental data do not clearly distinguish between the effect resulting from fentanyl and that possibly resulting from suxamethonium. However, as soon as the observed anaesthetic effect of our patients who had received both fentanyl and suxamethonium was dissipated, the resumption of spontaneous respiration signalled the return of a quality of awareness which was superior to that observed after mor-phine. We previously showed (Mostert et al., 1968) that there is a better recall of subsequent events after the administration of fentanyl than after injection of equipotent doses of pethidine. Fentanyl is often given in a dose of 0.5 mg as part of our anaesthesia for patients maintained on haemodialysis and who require major surgery. We have not encountered any prolonged central effects after such rather massive use of fentanyl. This is in accord with the experience of Grell, Koons and Denson (1970) .
Although we report on only two morphine recipients in the present study, a further six patients maintained on haemodialysis and given morphine 10 mg each also responded with an increase in cardiac output (Mostert et al., 1970b) . A species difference is therefore apparent between man and dog because a significant fall in cardiac output was documented by Pur-Shahriari and associates (1967) after morphine 0.25 mg/kg i.v. in the dog, and Morris and Zeppa (1963) ascertained its histamine-induced mechanism. Elliott and Abdel-Rahman (1965) pointed out that the haemodynamic effects of morphine in man are meagre, and that evidence from animal studies has been wrongly extrapolated to man. In man histamine release is known to result from the administration of morphine, but our data show that it does not lead to decreased cardiac output as it does in the dog. anaesthesia. This book is in their line of descent in terms of content and quality. Dr Lund gives us a scholarly, readable, comprehensive monograph which is both a reference book with an extensive bibliography, and a practical manual of detailed methods. There is hardly any aspect of spinal anaesthesia which is omitted. From history to pharmacology, from clinical techniques to complications, from indications to pros-and-consall is here. The writing is concise, the print is clear, and the illustrations, while few in number, are efficient in transmitting their message. If there was any regret in the reviewer's mind on reading this fine book, it was that, perhaps understandably, it is so American. Methods, quotations from authors, drugs, discussion, and the place of this technique, are all in relation to the American scene. Monumental works of this nature are best without an imprint of geographical or national boundaries. The second edition will undoubtedly soon be called for, and there will be an opportunity to make this work truly international in character by drawing on world literature more extensively. Its impact as a practical technical book for American doctors may be slightly less, but it would be enormously more attractive as a reference book for the researchers and clinicians of other countries. Even as it stands, this book is a landmark in anaesthetic literature and will be warmly welcomed everywhere. It is thoroughly recommended.
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Mechanical Artificial Ventilation (2nd edition). By Published by Charles C. Thomas, U.S.A. Pp. xiv T-160; illustrated. Price $8.50. This is essentially a short, practical and elementary book which will be helpful to junior anaesthetists and other clinicians who are not yet fully familiar with the problems of IPPV. In this second edition, only three years after the first, the author has not only made some revision of the text, but has extended the number of references and included a few more ventilators. The author is less happy dealing with mechanical matters than with physiological and clinical ones, and it is these latter sections, occupying the bulk of the book, that will be of interest. Naturally, coming from the United States, both the instruments described and the clinical environmental factors, so important in the medical and nursing care of patients on IPPV, are of that country. Nevertheless, British readers will find this a useful introductory volume. To them it is commended as a guide to current thinking and standards of care, in regard to IPPV in the U.S.A.
